Published in J Clin Microbiol on February 23, 2011
Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev (2013) 2.34
Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J Clin Microbiol (2012) 2.28
Comparison of the Microflex LT and Vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 2.13
Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev (2013) 1.37
Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories. J Clin Microbiol (2012) 1.21
Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes. J Clin Microbiol (2015) 1.15
Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes. Eur J Clin Microbiol Infect Dis (2013) 0.92
A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry. Med Sci Monit (2012) 0.91
Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J Clin Microbiol (2013) 0.90
Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother (2013) 0.88
Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management. Biomed Res Int (2014) 0.84
Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial Resistance. Front Microbiol (2016) 0.76
A novel selective medium for isolation of Bacteroides fragilis from clinical specimens. J Clin Microbiol (2016) 0.75
Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae. J Antibiot (Tokyo) (2016) 0.75
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis (2009) 16.51
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect (2010) 3.01
Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab (2009) 2.80
Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2009) 2.04
Fingerprint matching of E. coli strains with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of whole cells using a modified correlation approach. Rapid Commun Mass Spectrom (1998) 1.79
Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol (1995) 1.44
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother (2006) 1.23
Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob Agents Chemother (1999) 1.13
Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. J Med Microbiol (2004) 1.01
Expression of the carbapenemase gene (cfiA) in Bacteroides fragilis. J Antimicrob Chemother (2000) 0.99
Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes. Microbiology (2000) 0.99
Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Int J Antimicrob Agents (2006) 0.98
Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis. Clin Microbiol Infect (2008) 0.91
RecA and glnA sequences separate the bacteroides fragilis population into two genetic divisions associated with the antibiotic resistance genotypes cepA and cfiA. J Med Microbiol (2002) 0.89
Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. J Med Microbiol (2000) 0.88
Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene? J Antimicrob Chemother (2000) 0.81
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol (2012) 3.75
Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis (2013) 1.43
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28
Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol (2003) 1.27
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother (2006) 1.23
Presence in bovine enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) Escherichia coli of genes encoding for putative adhesins of human EHEC strains. Res Microbiol (2002) 1.19
Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother (2011) 1.14
HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability. BMC Infect Dis (2012) 1.12
Vitek 2 ANC card versus BBL Crystal Anaerobe and RapID ANA II for identification of clinical anaerobic bacteria. Anaerobe (2010) 1.08
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. BMC Infect Dis (2008) 1.02
Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis (2011) 1.02
Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol (2006) 1.00
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26. Antimicrob Agents Chemother (2010) 0.97
In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Int J Antimicrob Agents (2010) 0.96
Virulence profiling and quantification of verocytotoxin-producing Escherichia coli O145:H28 and O26:H11 isolated during an ice cream-related hemolytic uremic syndrome outbreak. Foodborne Pathog Dis (2010) 0.95
Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis. Appl Environ Microbiol (2004) 0.94
RegaDB: community-driven data management and analysis for infectious diseases. Bioinformatics (2013) 0.93
Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010. J Clin Microbiol (2012) 0.93
Prosthetic valve endocarditis caused by Bordetella holmesii, an Acinetobacter lookalike. J Med Microbiol (2012) 0.92
Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS Res Hum Retroviruses (2008) 0.92
Correct implementation of matrix-assisted laser desorption ionization-time of flight mass spectrometry in routine clinical microbiology. J Clin Microbiol (2010) 0.90
Modified real-time PCR for detecting, differentiating, and quantifying Ureaplasma urealyticum and Ureaplasma parvum. J Mol Diagn (2011) 0.89
Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother (2013) 0.88
Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants. J Clin Microbiol (2004) 0.87
Virulence profiling and disease association of verocytotoxin-producing Escherichia coli O157 and non-O157 isolates in Belgium. Foodborne Pathog Dis (2012) 0.86
In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis. BMC Pediatr (2012) 0.86
Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome. J Clin Microbiol (2013) 0.86
Species identification of clinical Prevotella isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 0.83
Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin Infect Dis (2003) 0.82
Pertussis serodiagnosis in Belgium from 1990 to 2009. Clin Vaccine Immunol (2011) 0.81
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients. J Cyst Fibros (2013) 0.81
Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines. Pediatr Pulmonol (2006) 0.78
Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples. J Clin Microbiol (2003) 0.78
Acceptance criteria for identification results of Gram-negative rods by mass spectrometry. J Med Microbiol (2011) 0.77
Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity. Retrovirology (2014) 0.77
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. Int J Antimicrob Agents (2012) 0.77
Integron characterization and typing of Shiga toxin-producing Escherichia coli isolates in Belgium. J Med Microbiol (2013) 0.76
Staphylococcus jettensis sp. nov., a coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol (2013) 0.76
In vitro activity of ertapenem against anaerobes isolated from the respiratory tract. Pathol Biol (Paris) (2003) 0.75
Detection of CMV DNA in the perilymph of a 6-year-old boy with congenital cytomegalovirus infection. Ear Nose Throat J (2016) 0.75
Enteropathogenic Escherichia coli O80:H2 in Young Calves with Diarrhea, Belgium. Emerg Infect Dis (2017) 0.75